227 related articles for article (PubMed ID: 17895509)
1. Hemostasis activation in thrombophilic subjects with or without a history of venous thrombosis.
Cuderman TV; Bozic M; Peternel P; Stegnar M
Clin Appl Thromb Hemost; 2008 Jan; 14(1):55-62. PubMed ID: 17895509
[TBL] [Abstract][Full Text] [Related]
2. Primary upper-extremity deep vein thrombosis: high prevalence of thrombophilic defects.
Hendler MF; Meschengieser SS; Blanco AN; Alberto MF; Salviú MJ; Gennari L; Lazzari MA
Am J Hematol; 2004 Aug; 76(4):330-7. PubMed ID: 15282664
[TBL] [Abstract][Full Text] [Related]
3. Thrombophilic variables do not increase the generation or procoagulant activity of thrombin during cardiopulmonary bypass.
Raivio P; Petäjä J; Kuitunen A; Lassila R
Ann Thorac Surg; 2008 Feb; 85(2):536-42. PubMed ID: 18222259
[TBL] [Abstract][Full Text] [Related]
4. Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome.
Rogolino A; Coccia ME; Fedi S; Gori AM; Cellai AP; Scarselli GF; Prisco D; Abbate R
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):277-82. PubMed ID: 12695751
[TBL] [Abstract][Full Text] [Related]
5. The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial.
Abou-Nassar K; Kovacs MJ; Kahn SR; Wells P; Doucette S; Ramsay T; Clement AM; Khurana R; Mackinnon K; Blostein M; Solymoss S; Kingdom J; Sermer M; Rey E; Rodger M;
Thromb Haemost; 2007 Jul; 98(1):163-71. PubMed ID: 17598009
[TBL] [Abstract][Full Text] [Related]
6. [Activation of hemostasis in patients with chronic cholecystitis].
Kłoczko J; Lewandowski JJ; Galar M; Mazgajska-Barczyk K; Panek M
Pol Merkur Lekarski; 2001 Jan; 10(55):19-20. PubMed ID: 11320544
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress and a thrombophilic condition in alcoholics without severe liver disease.
Trotti R; Carratelli M; Barbieri M; Micieli G; Bosone D; Rondanelli M; Bo P
Haematologica; 2001 Jan; 86(1):85-91. PubMed ID: 11146576
[TBL] [Abstract][Full Text] [Related]
8. Factor V Leiden in Greek thrombophilic patients: relationship with activated protein C resistance test and levels of thrombin-antithrombin complex and prothrombin fragment 1 + 2.
Lambropoulos AF; Foka Z; Makris M; Daly M; Kotsis A; Makris PE
Blood Coagul Fibrinolysis; 1997 Nov; 8(8):485-9. PubMed ID: 9491265
[TBL] [Abstract][Full Text] [Related]
9. [Thrombophilic syndrome associated to phenotypic resistance to activated protein C in postmenopausal women].
Caserta L; Caserta R; Torella M; Perricone F; Nesti E; Sessa M; Tagliaferri A; De Francesco F; De Lucia D; Panariello S
Minerva Ginecol; 2004 Apr; 56(2):131-6. PubMed ID: 15258541
[TBL] [Abstract][Full Text] [Related]
10. Reduced inhibition of activated prothrombin by heparin and venous thromboembolism: heparin resistance revisited.
Legnani C; Preda L; Palareti G; Lunghi B; Rossi E; Coccheri S
Haematologica; 2002 Feb; 87(2):182-8. PubMed ID: 11836169
[TBL] [Abstract][Full Text] [Related]
11. Enhanced thrombin generation in women with a history of oral contraception-related venous thrombosis.
Anžej Doma S; Vučnik M; Božič Mijovski M; Peternel P; Stegnar M
Thromb Res; 2013 Nov; 132(5):621-6. PubMed ID: 24083963
[TBL] [Abstract][Full Text] [Related]
12. [The thrombophilic status of patients with inflammatory diseases].
Lins M; Zurborn KH; Pries B; Bruhn HD
Dtsch Med Wochenschr; 1996 Jul; 121(27):855-9. PubMed ID: 8681740
[TBL] [Abstract][Full Text] [Related]
13. [Prothrombin fragment 1+2 (F1+2), thrombin-antithrombin III complex(TAT) and thrombophilia parameters in orally anticoagulated patients with inferior vena cava filters].
Halbmayer WM; Haushofer A; Toth E
Wien Med Wochenschr; 1993; 143(5):95-8. PubMed ID: 8511904
[TBL] [Abstract][Full Text] [Related]
14. Is plasminogen deficiency a thrombotic risk factor? A study on 23 thrombophilic patients and their family members.
Demarmels Biasiutti F; Sulzer I; Stucki B; Wuillemin WA; Furlan M; Lämmle B
Thromb Haemost; 1998 Jul; 80(1):167-70. PubMed ID: 9684804
[TBL] [Abstract][Full Text] [Related]
15. Coagulation activation and fibrinolytic imbalance in subjects with idiopathic antiphospholipid antibodies--a crucial role for acquired free protein S deficiency.
Ames PR; Tommasino C; Iannaccone L; Brillante M; Cimino R; Brancaccio V
Thromb Haemost; 1996 Aug; 76(2):190-4. PubMed ID: 8865529
[TBL] [Abstract][Full Text] [Related]
16. Thrombophilic genotypes, natural anticoagulants, and plasma homocysteine in myeloproliferative disorders: relationship with splanchnic vein thrombosis and arterial disease.
Amitrano L; Guardascione MA; Ames PR; Margaglione M; Antinolfi I; Iannaccone L; Annunziata M; Ferrara F; Brancaccio V; Balzano A
Am J Hematol; 2003 Feb; 72(2):75-81. PubMed ID: 12555209
[TBL] [Abstract][Full Text] [Related]
17. Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study.
Chaireti R; Jennersjö C; Lindahl TL
Thromb Res; 2009 Jun; 124(2):178-84. PubMed ID: 19232683
[TBL] [Abstract][Full Text] [Related]
18. Activation products of the haemostatic system in coronary, cerebrovascular and peripheral arterial disease.
van der Bom JG; Bots ML; Haverkate F; Meijer P; Hofman A; Kluft C; Grobbee DE
Thromb Haemost; 2001 Feb; 85(2):234-9. PubMed ID: 11246539
[TBL] [Abstract][Full Text] [Related]
19. Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease.
Cassar K; Bachoo P; Ford I; Greaves M; Brittenden J
Eur J Vasc Endovasc Surg; 2005 Feb; 29(2):171-6. PubMed ID: 15649725
[TBL] [Abstract][Full Text] [Related]
20. Levels of prothrombin fragment F1+2 in patients with hyperhomocysteinemia and a history of venous thromboembolism.
Kyrle PA; Stümpflen A; Hirschl M; Bialonczyk C; Herkner K; Speiser W; Weltermann A; Kaider A; Pabinger I; Lechner K; Eichinger S
Thromb Haemost; 1997 Nov; 78(5):1327-31. PubMed ID: 9408013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]